IP 13 (Alprazolam extended-release 3 mg)
Pill imprint IP 13 has been identified as Alprazolam extended-release 3 mg.
Alprazolam is used in the treatment of anxiety; panic disorder; depression; tinnitus; dysautonomia (and more), and belongs to the drug class benzodiazepines. There is positive evidence of human fetal risk during pregnancy. Alprazolam 3 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- IP 13
- Strength:
- 3 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Benzodiazepines
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Amneal Pharmaceuticals
- National Drug Code (NDC):
- 65162-0813
| NDC Code | Manufacturer / Repackager |
|---|---|
| 21695-0605 | Rebel Distributors Corp (repackager) |
Note: Inactive ingredients may vary.
More about alprazolam
Consumer resources
- Alprazolam
- Alprazolam extended-release tablets
- Alprazolam orally disintegrating tablets
- Alprazolam solution
- Alprazolam Oral (Advanced Reading)
- Other brands: Xanax, Xanax XR, Alprazolam Intensol, Niravam
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
